Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy
NACompletedINTERVENTIONAL
Enrollment
67
Participants
Timeline
Start Date
April 30, 2002
Study Completion Date
November 30, 2005
Conditions
Minimal Hepatic Encephalopathy
Interventions
DRUG
Acetyl-L-Carnitine
2 g acetyl-L carnitine twice a day
OTHER
placebo
placebo twice per day
Trial Locations (1)
95126
Cannizzaro Hospital, Catania
All Listed Sponsors
lead
University of Catania
OTHER
NCT01223729 - Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter